Pure Global
NCT05166902

Evaluation of Monthly Replacement Lenses in Habitual Soft Contact Lens Wearers Who Report Frequent Digital Devise Use

Evaluation of Monthly Replacement Lens Designs in Habitual Soft Contact Lens Wearers Who Report Frequent Digital Devise Use
Coopervision, Inc.·ClinicalTrials.gov·device·Device trialCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Ametropia
Drug/Device/Intervention
Lens A (comfilcon A lens)
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Coopervision, Inc.
Location
Ocoee,State College,Toronto,Toronto, Canada,United States of America
Timeline & enrollment
Phase
N/A
Start date
Jan 31, 2022
End date
Jul 09, 2022
Enrollment
67 participants
Primary outcome

Subjective Ratings on Lens Handling on Removal

Summary

To evaluate the clinical performance of two monthly silicone hydrogel contact lenses in
 habitual wearers of frequent replacement (FRP) lenses when worn for 1-month.

ICD-10 classifications
Amblyopia ex anopsiaAmoebiasisAmoebiasis, unspecifiedMyoclonusOesophagitis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05166902
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05166902 through Pure Global AI's free database. This phase not specified trial is sponsored by Coopervision, Inc. and is currently Completed. The study focuses on Ametropia. Target enrollment is 67 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.